Get started

Weedstocks

TCNNF Current Price $36 PT $50TCNNF | Shares (no options on this) TCNNF Current Price $36 Price Target $50 This company is a US based weed producer and retailer. Trueville cannabis is one of the rarely profitable cannabis firms. They are set to benefit greater than any other stock on the market from more states legalizing marijuana because they are a pure play US pot company. Why buy Canadian pot companies ( TLRY,ACB,SNDL) that aren't profitable when the real weed market is in the US. For example the state of California alone is a larger market for cannabis sales than the entire country of Canada. Long term holder of TCNNF, Its my top pick of the pot sector.
OTC:TCNNFLong
by Value-Invest
1
Bullish Setup on TLRY, we are ready to get high.Today we have a bullish setup on TLRY to share with you. We will be taking this setup using 1% of our capital, and we aim to make 4% on this setup. Of course, we can have a bad trip on this one... However, the risk-reward ratio is a key aspect of our strategy. Generally speaking, we have a win rate of 50% and an average risk-reward ratio of 2 (all you need to make money in the long term) Let's start with the view: -The price has been trending lower since February 2021. Now we are observing a possible change in trend, and we want to take advantage of this probable situation. -As you can see on the chart from May, we have been observing a sequence of higher highs, and higher lows + the price broke a key resistance zone (currently, we are observing a retest of that) -Based on all the previous items, we have defined but stop orders on the breakout of the current correction and stop orders below the structure. The target we will be aiming at is 29.5 with a protective level at 24.00 (there we will move our stop loss to break-even) If the price doesn't execute our setup and keeps going lower, we will cancel the setup. And if the price reaches our entry-level and our stop loss is executed. That's trading; we will face a -1% loss. Thanks for reading!
NASDAQ:TLRYLong
by ThinkingAntsOk
$FLOOF, The Largest MJ Cultivator in Nevada!(I'm not a professional, and I have no background in ... anything! Read this at your own discretion) Oh man, I've been seeing a ton of buzz about the booming progress of a reopened Las Vegas. Everyone's all, "Oh man, buy MGM and Caesars!" but I'm convinced that folks smarter than me have already done that- so the amazing strides the city has made in the last 3-6 months are likely priced in. ... Unless you know where to look. There's a lot of background to absorb with regard to Flower One's operations over the past two years, and I'm far too uneducated to explore it with any depth. My understanding is that some of their licensing deals were less-than-advantageous, and I'm aware of a transaction that fell through with Subversive Capital; I'm also guessing that their revenue estimates were a little too lofty, and the higher-than-expected previous cost of biological assets ate into the company's ability to operate profitably. Oops! Oh, and historically, their products had left a lot to be desired. I know what you're thinking: "consumers don't matter! it's stonks!!" Bro, I'm not paying $60 for weed that's bad on purpose . Nobody is. Was anybody really surprised when the Old Pal eighths weren't selling for $60? It was supposed to be a budget brand! This is a turnaround story; how we got here is important to note. Now let's talk about how it's going... Quality of products are way up. I'm saying this from an individual consumer perspective, but it's also evident in various social feeds. Folks used to frequently pile on the criticism about the quality of Flower One products, but in the last six months, that derision has turned into surprise almost across the board. There are a few vocal detractors who won't be won over without the "best, terp-fueled top shelf exclusive flower (45%THC!!)," but I'm betting that the majority of people will soon come to accept Flower One as a legitimately successful cultivator. +Bonus points for also being the largest in the state. Oh, sorry- I haven't mentioned that yet! Hey, take a minute over on Headset and tell me who is sitting comfortably with five or six spots in the top-selling flower category (for Nevada). Is it still $floof with the top three? They've held these spots for months in addition to top sellers in the vape cartridge category. I'm not a mathematician, but I get the feeling that they've sold a vast amount of marijuana products. It should be noted: the SKUs represented in Headset sales barely scratch the ramped-up production from the last three months. There are hundreds of additional products that I know for a fact are selling like fire. While it's true that they're paying licensing fees (I'm guessing!) to grow and sell the top-end products, I'm thinking that the sheer volume offsets any disadvantages attached to branded products. There's still a lot of risk here considering the delayed financials and the current debt load, but I'm personally waving off those concerns as necessary FUD. Heck, the "financial disclosure delay" situation is at least somewhat understandable considering the huge amount of work done restructuring the company's debt- the same auditor had a few other delays amongst other small cap marijuana companies, so I've got hope that it will all be appropriately sorted out in the coming days. Part of the restructuring deal was offering vendors equity, if I'm not mistaken- wouldn't they now have a vested interest in the success of the company? Personally, I'd think so. Anyway, I don't really know what I'm talking about. I'm not sorry if you've read this far- that's 100% on you. I've got a tiny baby cash account, so my positions and opinion don't matter.
OTC:FLOOFLong
by pleasesendhel
1
Aurora'ing back to life..will ACB burn one to get a yearly HIGH?EMA cross (50/200) on the 2hr chart, maybe back testing the 200 EMA now. Bresserts crossover on the weekly chart in oversold territory (last time this happened, it pumped $10 in the following 2 weeks - past performance not necessarily indicative of future results). CMF shows money flow is in positive territory, relative strength hovering just under 50 RSI. I'd like to see the price touch the $8.80-9.00 ideally, but the downside can be complete here. Semi-worst case it should hold $8.00 but still would not invalidate until major support is breached. Good R:R IMO... this one can be a volatile beast. It is possible we see a pump to the $10.90 region and a retrace to these levels again ($8.50-$9.50) before moving higher. Placing major support at $7.20, soon to move up to $7.60. Keep in mind this is the one traded on the NASDAQ in USD, so you'd have to convert support regions accordingly if trading on the TSX exchange chart. Inverted H&S formation points to $21-$23 region... but should go 'HIGH'er long term.
NASDAQ:ACBLong
by faronf
$GRWG Nearing A Breakout? Cannabis Sector Move?$GRWG Has had positive earnings and after holding the 200 EMA (orange line/Support) has bounced and broken downtrend. This candle held the break in downtrend, but I expect Monday we will potentially retest its resistance around 43.50 Positive Earnings from companies like $CGC and $HEXO in the coming weeks could help push cannabis sentiment, but GRWG does run by itself due to being in the lucrative craft of selling cannabis growing equipment and materials which is perfectly legal and doesn't have to go through a banking run around. Looking at 47.50 as my first target going into next week. Volume in comparison to previous sessions is low, and with that I wont be taking any sizable positions until I do. $GRWG trading requires high time frame observation in order to verify the price is still in trend, as it isn't a huge daily mover but does tend to gap up quite well. If we manage a decent run and market willing we could see $GRWG hit the psychological target of $50 Upon a break of $50 my first target will be 53.50 between June and August. $55 as a PT seems to be the consensus amongst analyst. I will be doing a video breakdown on this tomorrow. To go more in depth. I actually like the stock
NASDAQ:GRWGLong
by SimpleStacks
Tilray to $30 -- getting highThis is strictly a technical analysis of Tilray and nothing more -- their financials are garbage and the stock is currently overpriced, but what isn't... I think RSI is in a good spot on the daily to really run up. Price has been rising along with volume, confirming the market's interest in taking Tilray to higher prices. First target is $22, and then second target would be $30. I am foreseeing a larger harmonic structure forming here with price rising to $30, which coincides with the .5 fib. This is not the optimal place to enter this trade, but if you have the kahunas on you, then by all means go ahead and long here.
NASDAQ:TLRYLong
by thejdela
2
WEED STOCK THOUGHTS! HEXO, ACB, APHAHey everyone! Here with a video on some Cannabis Stocks I've been checking out. (THIS VIDEO, HEXO, APHA, ACB) Day time frame: Most of the cannabis stocks are looking very similar. -completed Market Cycle -Down 80-100% -lower MA's have crossed north, or are close to crossing 200MA in Bullish form IMO these are looking like great places to invest if you wish to do so. I am no financial advisor, just a trader sharing my thoughts and ideas! PLEASE LIKE COMMENT AND FOLLOW! AND REMEMBER, DON'T CHASE IT, RETRACE IT!
OTC:NUGSLong
by Cosmicbag